CHRISTOPHER LUNSETH: Open Payments
NPI 1730299371 · MARQUETTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 11 payments from 7 companies in 2025. Trend: 2023 $244 · 2024 $78 · 2025 $212
Food & beverage: $178Education: $34
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| Amgen Inc. | 1 | $34 |
| Regeneron Healthcare Solutions, Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Genentech USA, Inc. | 1 | $22 |
| Stryker Corporation | 1 | $16 |
Products named: NUCALA, Xolair, DUPIXENT, TEZSPIRE, Rhapsido, SCOPIS ENT.
Industry payments across MI — which companies pay providers there.
